Previous 10 | Next 10 |
Image source: The Motley Fool. Codex DNA, Inc. (NASDAQ: DNAY) Q2 2022 Earnings Call Aug 09, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Codex DNA, Inc. (DNAY) Q2 2022 Earnings Call Transcript
Codex DNA press release ( NASDAQ: DNAY ): Q2 GAAP EPS of -$0.50. Revenue of $5.7M (+100.0% Y/Y). For the full year 2022, Codex DNA provided the following updated financial guidance : Total revenue in the range of $22 million to $24 million vs....
SAN DIEGO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today reported financial results for the second quarter ended June 30, 2022. Recent Highlights Continued execution across all areas of the gr...
SAN DIEGO, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that it will release its second quarter 2022 financial results on Tuesday, August 9, 2022, after the market closes. In conjunction with the...
Aspen Aerogels ( ASPN ) +42% following its decision to not advance with stock and debt offering. Codex DNA ( DNAY ) +15% . Mullen Automotive ( MULN ) +12% . Adagene ( ADAG ) +7% on $10M share buyback. SoundHound ( SOUN ) +7% ...
Gainers: 22nd Century Group (XXII) +29%. Wave Life Sciences WVE +16%. Codex DNA (DNAY) +13%. F-star Therapeutics (FSTX) +12%. Sorrento Therapeutics (SRNE) +12%. Losers: Athira Pharma ATHA -70%. Neptune Wellness Solutions NEPT -32%. 4D pharma (LBPS)...
Ocean Bio-Chem (OBCI) +115%to acquire Ocean Bio-Chem in ~$125M all-cash deal. Revlon (REV) +29%. Codex DNA (DNAY) +26%. Boxed (BOXD) +19%. Green Giant (GGE) +10%. Comera Life Sciences Holdings (CMRA) +9%. La-Z-Boy (LZB) +8%surge on record sales, operating income. Rigel Pharmaceuticals (RIGL) ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: ventdusud / Shutterstock.com It’s time to start off another busy day of trading with a look at the biggest pre-market stock movers for Wednesday! Moving stocks this morning is earnings news, an acquis...
SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that Todd R. Nelson, PhD, the company’s chief executive officer, will present at the 2022 Jefferies Healthcare Conference on Friday,...
BioXp™ system and RapidAMP™ cell-free DNA kit rapidly accelerate antibody discovery pipelines by addressing critical bottlenecks associated with lead candidate gene synthesis, cloning, and scale-up SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq:...
News, Short Squeeze, Breakout and More Instantly...
Codex DNA Inc. Company Name:
DNAY Stock Symbol:
NASDAQ Market:
-- Record revenue of $6.7M in 3QFY22; Increase of 140% over $2.8M 3QFY 2021 -- BioXp® Kit Revenue increased to $884k, or 69% in 3QFY22 over 3QFY2021 -- Increases revenue guidance to $23 million to $25 million for the full year fiscal 2022 SAN DIEGO, Nov. 08, 2022 (GLOBE N...
SAN DIEGO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its third quarter 2022 financial results on Tuesday, November 8, 2022, after the market closes. In conjunction ...
SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, and Cellibre, a leading manufacturing technology company, today announced initiation of work under a collaboration to optimize the development and valid...